Form 4: Zoetis Executive Jamie Brannan Reports Stock Transactions
SEC Form 4 Filing
Executive Vice President Jamie Brannan reports transactions involving Zoetis Inc. common stock, including acquisitions from restricted stock unit vesting and dispositions to cover tax obligations.
Summary
- Jamie Brannan, an Executive Vice President at Zoetis Inc., filed a Form 4 detailing changes in beneficial ownership of the company's stock.
- On February 8, 2025, Brannan acquired 374 shares of common stock upon the vesting of restricted stock units (RSUs).
- Also on February 8, 2025, Brannan disposed of 176 shares of common stock at a price of $171.43 to satisfy tax obligations related to the RSU vesting.
- Brannan also acquired 289 shares of common stock upon the vesting of additional restricted stock units (RSUs).
- Additionally, on February 8, 2025, Brannan disposed of 137 shares of common stock at a price of $171.43 to satisfy tax obligations related to the RSU vesting.
- Following these transactions, Brannan directly owns 2,171 shares of Zoetis Inc. common stock.
- Brannan also indirectly owns 418 shares through the UK Share Ownership Plan.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions, with no inherent positive or negative sentiment.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to track executive compensation and ownership trends.
Comparison to Industry Standards
- Executive compensation packages often include restricted stock units (RSUs) that vest over time, aligning executive interests with long-term shareholder value.
- The disposal of shares to cover tax obligations upon RSU vesting is a common practice among executives.
- Companies like Elanco Animal Health and Merck Animal Health, competitors of Zoetis, also have executives who regularly report similar transactions via Form 4 filings.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they represent routine executive compensation activities.
- Shareholders can monitor insider transactions for insights into management's perspective on the company's stock.
Key Dates
| Date | Description |
|---|---|
| 02/08/2022 | Date of grant for restricted stock units that vest on the third anniversary. |
| 02/08/2023 | Date of grant for restricted stock units that vest in three annual installments. |
| 02/06/2024 | Date of grant for restricted stock units that vest in three annual installments. |
| 12/31/2024 | Date for common stock equivalents held in the UK Share Ownership plan. |
| 02/08/2025 | Date of stock transactions: RSU vesting and stock disposal for tax obligations. |
| 02/11/2025 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.